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Pseudomonas syringae strains deliver variable numbers of type III
effector proteins into plant cells during infection. These proteins
are required for virulence, because strains incapable of delivering
them are nonpathogenic. We implemented a whole-genome, high-
throughput screen for identifying P. syringae type III effector
genes. The screen relied on FACS and an arabinose-inducible hrpL
 factor to automate the identification and cloning of HrpL-
regulated genes. We determined whether candidate genes encode
type III effector proteins by creating and testing full-length protein
fusions to a reporter called 79AvrRpt2 that, when fused to known
type III effector proteins, is translocated and elicits a hypersensitive
response in leaves of Arabidopsis thaliana expressing the RPS2
plant disease resistance protein. 79AvrRpt2 is thus a marker for
type III secretion system-dependent translocation, the most critical
criterion for defining type III effector proteins. We describe our
screen and the collection of type III effector proteins from two
pathovars of P. syringae. This stringent functional criteria defined
29 type III proteins from P. syringae pv. tomato, and 19 from P.
syringae pv. phaseolicola race 6. Our data provide full functional
annotation of the hrpL-dependent type III effector suites from two
sequenced P. syringae pathovars and show that type III effector
protein suites are highly variable in this pathogen, presumably
reflecting the evolutionary selection imposed by the various host
plants.
host–microbe interaction  plant pathogenesis  Arabidopsis  FACS
The commonly studied plant bacterial pathogen, Pseudomonassyringae, is subdivided into pathovars based on their ability
to cause disease on one or more distinct host species. During
infection, P. syringae and other Gram-negative pathogens deliver
type III effector proteins via a type III secretion system (TTSS)
(hrphrc genes in P. syringae; ref. 1) from the bacterium into host
cells (2). P. syringae strains incapable of delivering type III
effectors are nonpathogenic (3). Thus, the type III effectors each
strain delivers are required for pathogenicity. In contrast, if just
one of the type III effectors is ‘‘recognized’’ by the plant immune
system’s surveillance machinery [disease resistance (R) pro-
teins], a battery of host responses is triggered, including localized
programmed cell death, termed the hypersensitive response
(HR) (4). In this case, the pathogen is rendered avirulent; its
multiplication is limited, and it does not cause disease. As a
consequence, some type III effector genes have been function-
ally defined as avirulence (avr) genes. Recognition of type III
effector proteins by corresponding R proteins may therefore
limit the particular host range of individual P. syringae pathovars.
P. syringae type III effector genes share several characteristics.
Their expression is coordinately regulated with the TTSS-encoding
genes by the alternative  factor, HrpL (5). Genes encoding both
the TTSS and type III effector proteins also share a cis-element
(hrp-box) in their promoters (6). Finally, delivery of type III effector
proteins into the host cell depends on the TTSS and a loosely
defined N-terminal signal in the type III effector protein that
includes 10% serine or proline in the first 50 aa, an aliphatic
amino acid or proline at position 3 or 4, and the absence of
negatively charged amino acids in the first 12 residues (7–9).
Nonsaturating genetic screens have relied on these characteris-
tics. Guttman et al. (9) identified 15 protein fusions defining genes
whose N termini were sufficient for TTSS-dependent translocation.
These included 12 previously uncharacterized type III effector
proteins. Boch et al. (10) identified genes that were induced by in
planta conditions and regulated by HrpL in vitro. Six of these
encoded previously identified type III effector proteins. Bioinfor-
matic approaches relying on the predicted shared characteristics of
type III effector genes have also been used to identify candidate
type III effector genes. The genomes of three P. syringae pathovars,
tomato race DC3000 (Pto) (www.pseudomonas-syringae.org),
phaseolicola race 6–1448a (Pph6) (www.pseudomonas-syringae.
org), and syringae race B728a (Psy) (www.jgi.doe.govindex.html)
have been sequenced (11). Genes encoding putative type III
effector proteins and helpers, referred to as hop (hrp-dependent
outer protein) genes were identified in these genomes by the
presence of putative hrp-boxes (12, 13), and ORFs with N-terminal
amino acid compositions consistent with known Hops (8, 9, 14, 15).
Helper proteins are secreted from the bacterium via the TTSS but
likely do not function within the host cell. Their presumptive roles
are to assist the TTSS in delivery of type III effector proteins (15).
From these efforts, Pto was estimated to deliver 40 different Hops
(7–10, 12–15). Far fewer Hops were predicted in Psy B728a (14).
Thirty Hops were predicted from Pph6 based on homology to
known and predicted Hops from other strains (16). The exact
number of type III effector proteins based on these predictions has
not been experimentally validated.
We modified a technique termed differential fluorescence in-
duction (DFI) (17) for high-throughput discovery of HrpL-
regulated genes from pathovars of P. syringae. Genomic libraries of
P. syringae were screened for clones expressing GFP in a HrpL-
dependent manner by using FACS. Identified clones were se-
quenced and assembled. Resulting contiguous DNA sequences
(contigs) were examined for the characteristics of type III effector
genes mentioned above. We amplified and cloned full-length
candidate genes in-frame to the coding region of the C-terminal 177
aa of the type III effector protein AvrRpt2, from which the
N-terminal 79 aa are deleted (79AvrRpt2; refs. 9, 18, and 19).
Cells expressing these fusion proteins were infiltrated into plants
expressing RPS2, the R protein that ‘‘recognizes’’ AvrRpt2, to
determine which of the candidate genes encode proteins that can
translocate 79AvrRpt2, and are hence type III effector proteins.
Abbreviations: TTSS, type III secretion system; R, disease resistance; HR, hypersensitive
response; Pto, P. syringae pv. tomato race DC3000; Pph6, P. syringae pv. phaseolicola race
6-1448a; Psy, P. syringae pv. syringae; DFI, differential fluorescence induction; Hop, Hrp-
dependent outer protein.
Data deposition: Sequences corresponding to genes identified in Pph6 have been depos-
ited in the GenBank database [accession nos. AY803993 (avrB3), AY803994 (hopAT1),
AY803995 (hopAU1), AY803996 (hopAV1), AY803997 (hopAW1), and AY803998 (HrpL-
regulated gene)].
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We present our method and analyses of the type III effector suites
from Pto and Pph6. Our data provide full functional annotation for
the HrpL-regulated type III effector proteins from these two
strains, and provide a tool with which to characterize the type III
effector suites from the entire range of P. syringae pathovars. The
two strains carry different sets of type III effectors. Essentially all
of the type III effector genes are located in nonorthologous
positions in the respective genomes. These findings suggest that
type III effector suites are evolutionarily very fluid, and that host
range can be limited by ‘‘recognition’’ of type III effector protein by
host R proteins, as well as by the lack of positive virulence functions
in the pathogen.
Methods
Bacterial Strains and Growth Conditions. P. syringae strains Pto,
PtohrpL and Pph6 (all rifampicin resistant) were grown in King’s
B (KB) media at 28°C with shaking or on KB media agar plates at
28°C. Before FACS sorting, PtohrpL was grown in minimal media,
modified from ref. 20 to include 1% glycerol, 0.5% dextrose, 10 mM
L-glutamate with or without 200 mM or 75 mM L-()-arabinose
(Supporting Text, which is published as supporting information on
the PNAS web site), at 28°C with shaking. Escherichia coli DH5
was used in all cloning procedures and grown on LB agar plates or
in SOB media at 37°C with shaking. The following antibiotics were
used for both P. syringae and E. coli: 50 gml rifampicin, 30 gml
kanamycin, 5 gml tetracycline (10 gml for agar plates), and 25
gml cyclohexamide. PtohrpL was provided by B. Staskawicz
(University of California, Berkeley).
Construction of Plasmids. pCFS40 (21) was modified to carry an
idealized Shine–Delgarno sequence from gene10 of phage T7,
upstream of hrpLPto (Supporting Text). Another vector, pBBR1-
MCS2 (22), was modified to carry in three different reading frames,
an operon fusion of 79avrRpt2 followed by GFP3 (23). The
operons are flanked by RNA terminators (Supporting Text). These
are referred to as DFI vectors. The vector in frame 1 was converted
into a Gateway-ready vector by digesting with SmaI and ligating in
conversion cassette C.1 (Invitrogen).
Library Construction. DNA was extracted from P. syringae (24),
purified by using CTAB (25), and either partially digested with
Tsp509I, AluI, BstUI, HaeIII, or RsaI or physically sheared by using
a double stroke shearing device (Fiore Automation, Salt Lake City,
UT). Fragments from 0.5–0.8 kb, 0.8–1.4 kb, and 1.4–2.0 kb were
extracted and cloned into either EcoRI- or SmaI-digested and
shrimp alkaline phosphatase (SAP)-treated DFI vectors. E. coli
colonies carrying clones of similarly sized ligation products were
pooled and mated en masse by modified triparental mating (P.
Ronald, personal communication), with PtohrpL  pBAD::hrpL
and pRK2013.
Construction of Full-Length Gene Fusions. Candidate HrpL-induced
gene fragments were amplified from cells harboring the DFI
plasmids (Supporting Text). Contigs were assembled and layered
onto the genome sequences of Pto or Pph6 (ref. 11 and www.p-
seudomonas-syringae.org). Full-length genes and operons were
cloned by two-step PCR (Supporting Text). PCR products were
recombined by BP reaction into pDONOR207 following the man-
ufacturer’s recommendations (Invitrogen). All products were se-
quenced and then recombined into DFI vector 1 by using LR
(Invitrogen). Candidate genes were individually mated into Pto 
pBAD::hrpL by triparental mating (P. Ronald, personal commu-
nication) with pRK2013.
FACS. FACS was performed on a MoFlo (Cytomation). Analysis by
FACS was performed on a FACscan from Becton Dickinson. One
microliter of overnight culture cells was diluted into 400 l of 1
PBS. Events shown in histograms (GFP, FL1) were gated on both
side scatter (SSC) and forward scatter. Both were detected in log,
and events were triggered on SSC. A total of 10,000 events were
collected for each analysis (see Supporting Text).
Plant Infiltrations. Infiltrations of leaves of Arabidopsis rpm1–3 were
done as described (26). The HR was scored blind no more than 26 h
after inoculation. Results were compared to leaves infiltrated with
Pto carrying a HrpL-regulated full-length avrRpt2 or an empty
vector.
Results
Vectors and Library Construction for DFI. We created three DFI
vectors for ‘‘trapping’’ HrpL-regulated promoters (Fig. 1A and
Supporting Text). These have cloning sites, in all three reading
frames upstream of a promoterless avirulence gene lacking the
N-terminal coding 79 aa (79avrRpt2; refs. 9, 18, and 19). Following
79avrRpt2 in these DFI vectors is a promoterless GFP3 gene (23).
We also created pBAD::hrpL, a separate vector with an arabinose-
inducible hrpLPto (hrpL; Supporting Text). DNA fragments from Pto
or Pph6 were cloned into each of the three DFI vectors and
mobilized into PtohrpL conditionally complemented with
pBAD::hrpL. The library representation was at least 10-fold excess
for each genome in each reading frame.
The DFI Screen for Pto HrpL-Regulated Genes. Pto was screened for
HrpL-regulated genes by using FACS as described in Fig. 1 and the
Supporting Text. We identified 43 HrpL-regulated genesoperons
(Supporting Text, Table 2, and Fig. 3, which are published as
supporting information on the PNAS web site). Five conserved
HrpL-regulated TTSS promoters, hrpA, hrpF, hrpJ, hrpP, and hrpK
(27), were present in contigs represented by many different clones
in Pto as well as Pph6, supporting the contention that the screens
were near saturating (Table 2). Fifty-nine hop genes were previ-
ously proposed in Pto and their protein products were classified
(www.pseudomonas-syringae.org) as type III effector proteins or
helper proteins, based on biological tests (15), or as candidate Hops
(14, 15). We found only 29 of the 39 proposed effectors and helpers.
Eight of the 10 genes we missed either lacked hrp-boxes, are
potentially in operons, andor are located on an endogenous
plasmid (Table 2 and www.pseudomonas-syringae.org) that our lab
isolate of Pto lacks (data not shown). Therefore, only two of the
previously identified hop genes were actually missed in our screen:
hopAA1–2 and schV-hopV1. We also found eight of the 20 genes
previously listed as candidate hop genes (www.pseudomonas-
syringae.org ) and seven that were previously suggested to be
HrpL-regulated or previously unidentified (Table 2 and ref. 10).
We created 61 full-length gene fusions to 79avrRpt2::GFP3,
accounting for 50 of the 59 predicted hop genes (from the plasmid-
bearing strain of Pto; ref. 11 and www.pseudomonas-syringae.org).
We included 10 categorized hop genes (two that escaped our screen,
four that lack hrp-boxes, and four that are located on the endog-
enous plasmid), and 13 additional candidate hop genes (eight of
which were identified in our screen, five of which were not).
Forty-seven of these 61 gene fusions exhibited HrpL-dependent
induction (Table 1 and Table 3, which is published as supporting
information on the PNAS web site). We observed a strong corre-
lation between HrpL-induction and the presence of a hrp-box. Nine
of 11 predicted genes without predictable hrp-boxes were not
induced by HrpL, but seven of these were induced when cloned as
operon fusions to their respective upstream genes that do contain
hrp boxes (Table 3, not bold). Only two possible operons with clear
hrp boxes were not induced by HrpL in our assays (Table 3).
The DFI Screen for Pph6 HrpL-Regulated Genes. We also screened
Pph6 and identified 41 HrpL-induced genes or operons (Table 2),
including 23 of the 30 predicted hop genes in Pph6 (16). Forty-five
genesoperons were fused to 79avrRpt2::GFP3 (Table 2). We
elected not to retest seven other predicted candidate hop genes (16);
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two corresponded to hrpZ and hrpK of the hrphrc cluster, the other
five were not identified in our screen and have no functional
characteristic of a type III effector gene ascribed to them. We
confirmed that 36 of 45 fusions were HrpL-induced (Tables 1 and
3). These defined 35 genes, including 21 of the 23 predicted hop
genes of Pph6 identified in our screen.
Characterization of HrpL-Induced Proteins for Delivery into Plants.
TTSS-dependent translocation of full-length proteins into plant
cells is the most direct and most stringent test for defining type III
effector proteins (14). All full-length fusions to 79AvrRpt2 de-
rived from Pto and Pph6 described above (in wild-type Pto), were
infiltrated into leaves of RPS2-expressing plants, relying on induc-
tion of the endogenous HrpL by in planta conditions. This exper-
iment determines which candidate genes encode type III effector
proteins, but it will not identify helper proteins. We also analyzed
the translated sequences of all of the genes for putative TTSS-
dependent sequences (Tables 1 and 3 and refs. 8, 9, 14, and 15).
These characteristics include 10% serine or proline in the first 50
aa, an aliphatic amino acid or proline at position 3 or 4, and the
absence of negatively charged amino acids in the first 12 residues.
We found a high correlation between experimentally translocated
proteins and those having amino acids consistent with at least two
of the proposed secretion signal rules (Table 1). Proteins that were
unable to deliver 79AvrRpt2 generally had discordance with these
rules or were not HrpL-regulated (Table 3).
Twenty-five proteins from Pto reliably elicited RPS2-dependent
HR in multiple experiments (Table 1). Twenty of these were
identified in our screen; five were missed for reasons defined above.
Thirty-two of the 61 fusion proteins consistently failed to elicit the
HR (Table 3). AvrPphEPto (HopX1) and HopG1 elicited weak,
inconsistent HR. Nevertheless, we classified them as type III
effector proteins. We were unable to clone full-length genes of
hopR1 or avrE1Pto, but we cautiously list them as type III effectors
based on orthology to known type III effector proteins. The sum of
our HrpL-dependent expression data and 79avrRpt2 transloca-
tion data (Tables 1 and 3) suggests that the previous informatics-
based predictions significantly overestimated the number of type III
effector genes in Pto (www.pseudomonas-syringae.org and refs. 7,
14, and 15). We conclude that Pto has at least 24, and possibly 28,
HrpL-regulated, translocated type III effector proteins, plus
hopO1-2, which is apparently translocated but HrpL-independent.
Seventeen fusion proteins from Pph6 reproducibly elicited an HR
(Table 1). Twelve of these proteins had been predicted based on
homology to other Hops (16). We additionally found a member of
the AvrB family (28) not previously identified in Pph6 (16); we
named this protein AvrB3Pph6. HopM1Pph6 and AvrEPph6 fusions to
79avrRpt2 did not elicit reliable HR phenotypes, but were cau-
tiously classified as type III effectors based on orthology to known
proteins that traverse the TTSS (Table 1 and ref. 29). Twenty-seven
Pph6 fusion proteins consistently failed to elicit an RPS2-dependent
HR (Table 3). Twenty corresponded to genesoperons identified in
our screen, and are therefore HrpL-regulated, but not delivered to
host cells. One of them, HopV1Pph6, did not give a reliable HR, and
its translated sequence is not similar enough to the translocated
HopV1Pto to use orthology in classifying HopV1Pph6 as a type III
effector protein. The N-terminal regions do not align and
HopV1Pph6 is 244 residues longer than HopV1Pto. The remaining
seven proteins correspond to predicted Pph6 homologs of Pto
candidate type III effector genes (Table 3). We conclude that Pph6
encodes at least 17, and possibly 19, HrpL-regulated and translo-
cated type III effector proteins.
Identification of Four Previously Undescribed Type III Effectors in
Pph6. We identified four previously undescribed type III effector
proteins in Pph6 (Table 1 and Table 4, which is published as
Fig. 1. A high-throughput, FACS-based screen for P. syringae type III effector genes. (A) Diagram depicting the flow of our screen. Libraries were constructed
in DFI vectors 1–3 upstream of 79avrRpt2::GFP3 and mobilized into Pto carrying pBAD::hrpL. Clones carrying HrpL-regulated inserts were isolated in a four-step
process using FACS. Cells were first grown in modified minimal medium lacking arabinose, and the least fluorescent 30% of cells were collected to eliminate
those constitutively expressing GFP. These 200,000 cells were subsequently grown in minimal medium with arabinose, and a small population of cells with the
highest level of GFP expression, compared to those of a negative control population grown in the absence of arabinose, were collected by FACS (see B). These
two steps were repeated, except that the GFP-positive cells were individually cloned by FACS after the second arabinose induction. DNA inserts were amplified,
sequenced, and assembled. Contigs were analyzed, and full-length genes and operons were identified, cloned upstream of 79avrRpt2::GFP3, and tested for
HrpL-induction as well as translocation of 79AvrRpt2 into leaves of RPS2-expressing plants. (B) Three FACS histograms from the screen for HrpL-induced genes
from Pto. Histogram 1 shows distribution of GFP-fluorescence of the original library before any enrichment. The boxed area represents the region that was FACS
cloned (least fluorescent 28.82% with a mean of 5.73. Histogram 2 shows distribution of GFP-fluorescence after growth in arabinose. A fluorescent population
of the brightest 0.44% (mean of 227.66) of cells was sorted (compared to 0.34% and 147.24, respectively, in the same fluorescence range in uninduced controls
of the same cell population). Histogram 3 shows distribution of GFP-fluorescence after all four FACS enrichment steps. The boxed area represents the region from
which individual cells were FACS cloned; 4.66% with a mean of 325.50 versus 0.42% and 231.13, respectively, for the uninduced negative control. Each histogram
represents at least 40,000 cells. x axis shows GFP fluorescence in log. y axis shows number of cells in each channel.









supporting information on the PNAS web site). HopAT1 is pre-
dicted to be only 88 aa long. HopAU1 and HopAV1 have homology
to predicted proteins from two pathovars of Xanthomonas and
Ralstonia, respectively. A HopAV1 ortholog was identified in a
screen for HrpB-induced genes of Ralstonia (30). HopAW1 has
homology to the translated product of the so-called ORF3 from the
pAV511 plasmid of Pph race 7 (31), except that ORF3 from Pph
race 7 has a 10-bp deletion relative to that of Pph6, potentially
truncating the protein to 90 residues.
Pto and Pph6 Share 13 Type III Effector Proteins. These common
proteins are, largely, highly related, and homology in most cases
spans the length of the deduced protein (Fig. 2A). However, when
we compared the genomic context of all of the type III effector
genes (Fig. 2B and Supporting Text) only the avrE1 and hopM1
genes from each strain are immediately flanked by orthologous
ORFs. Both of these genes are adjacent to the hrphrc cluster,
within the conserved effector locus of each strain (27). Two other
orthologs share one common flanking ORF, but have rearrange-
ments relative to one another on their other side. In this case, the
five predicted ORFs 5 to hopI1Pto and hopI1Pph6 are orthologous
and colinear (Fig. 2C). In contrast, although only 2.5 kb of DNA
separates hopI1Pph6 from its 3 neighboring ORF, 40.2 kb and six
mobile element-like genes separate hopI1Pto from the same 3
orthologous ORF. Interestingly, the chromosomal virPphAPto
(hopAB2Pto) is flanked by ORFs that are orthologous to those
flanking the nontranslocated virPphAPph6 (hopAB3Pph6) gene lo-
cated on the Pph6 chromosome (Fig. 2C), but not to those that flank
the translocated virPphAPph6 (hopAB2Pph6) that resides on the Pph6
plasmid.
AvrPphEPph6 (hopX1) is part of the hrpK operon. By contrast,
avrPphEPto (hopX1) is located on an endogenous plasmid (15).
Likewise, avrPphD (hopD1), hopQ1, and avrRps4 (hopK1) are
located on the plasmid of Pph6, but orthologs are found on the Pto
chromosome (Fig. 2B). AvrPphD (hopD1) and hopQ1 are separated
by 116 bp in both Pto and Pph6. The 116-bp spacer regions differ
by only 3 bp between the two strains. However, there is no other
apparent conservation of flanking orthology between these genes
as they have shuttled between chromosome and plasmid. The
remaining common type III effector genes were found scattered
throughout the chromosomes of their respective strains and do not
share common flanking ORFs with their orthologs.
Discussion
P. syringae pathovars rely on their suites of type III effector
proteins to colonize evolutionarily diverse plant hosts spanning
200 million years of evolution (32). These proteins manipulate
the eukaryotic host cell to suppress host defense responses,
facilitate nutrient acquisition, and contribute to colony size and
spread (33, 34). A detailed understanding of the sets of type III
effector genes in strains across this bacterial species will help
unravel how host range is determined. For example, Pto is an
aggressive Arabidopsis pathogen, but no strain of Pph is able to
cause disease or trigger hypersensitive cell death on this host. Pto
and Pph share 13 type III effector proteins. We reason that this
set in Pph6 is insufficient for pathogenicity on Arabidopsis. This
finding implies that one or more of the 16 extra-Pto type III
effectors, perhaps in combination with the shared set, would
render Pph6 pathogenic on Arabidopsis. Conversely, Pph6 is a
pathogen of bean, and its set of 19 type III effector proteins is
sufficient for pathogenicity, apparently in combination with the
right set of host target alleles. However, Pto triggers an HR on
bean. This finding suggests either that one or more of the 16
extra-Pto type III effectors is recognized by bean plants or allelic
differences in one or that more of the 13 shared type III effector
proteins in Pto allow for its recognition by bean. Only through
definition of the entire type III effector gene suite can these
hypotheses be evaluated carefully.
Table 1. Full-length proteins of P. syringae capable of delivering
79AvrRpt2 into plant cells
Protein Score† Ind‡
Translocation signal*
% S Aliph. AA Lack-AA
Pto
Group 1
HopK1 4.00 18 4(I) Y
HopY1 7.3 19.33 16 3(I) Y
HopH1 17.2 45.33 10 4(P) Y
HopC1 9.4 43.67 16 3(I) 4(V) Y
HopD1 10.0 7.50 14 3(P) 4(L) Y
HopQ1 13.6 14.67 24 4(P) Y
HopAM1-1 5.6 23.33 16 N Y
HopAA1-1 11.4 7.25 18 3(I) Y
HopAF1 5.9 5.50 26 3(L) Y
HopP1 10.4 19.25 20 N Y
HopAB2 15.2 19.43 18 4(I) Y
AvrPto1 19.3 36.00 16 4(I) Y
HopE1 16.0 46.00 14 4(V) Y
HopAA1-2 6.8 1.79 20 3(I) Y
HopAR1 7.7 6.50 20 3(P) 4(L) Y
HopI1 7.9 17.83 14 4(L) Y
HopAM1-2 5.6 25.50 16 N Y
Group 2
HopO1-1 5.1 14.50 24 4(I) Y
HopV1 5.4 10.00 6 N N
HopO1-2§ 11.4 1.00 28 3(I) Y
HopF2 12.3 1.83 20 3(I) Y
HopN1 6.0 8.67 14 3(I) Y
HopM1 3.0 23.00 10 N Y
HopB1§ 8.0 25.50 12 3(P) 4(V) Y
HopA1 6.7 18.00 10 3(P) 4(I) Y
Group 3
HopR1¶ 12.8 3.13 18 4(V) Y
AvrE1¶ 11.2 NT 16 4(P) Y
HopX1 4.2 1.67 14 3(I) Y
HopG1 10.4 19.33 10 3(I) Y
HopB1§ 1.00 12 3(P) 4(V) Y
HopO1-2§ 1.00 28 3(I) Y
Pph6
Group 1
AvrB3 8.7 20.83 20 4(I) Y
HopAB2 0.5 3.00 16 4(I) Y
HopAU1 9.1 11.60 10 3(P) 4(V) Y
HopG1 8.1 9.67 14 3(I) Y
HopK1 16.78 24 4(I) Y
HopAW1 7.7 22.40 10 3(V) Y
AvrB2-3 9.1 18.33 26 4(V) Y
HopQ1 13.6 11.00 22 4(P) Y
HopW1-1 6.4 16.00 18 3(P) Y
HopAV1 7.8 2.25 14 N Y
HopAF1 7.0 17.67 24 3(L) Y
HopD1 10.0 21.25 14 3(P) 4(L) N
HopI1 7.4 23.00 16 4(L) Y
HopAT1 1.2 13.20 8 4(I) Y
HopR1 9.9 4.73 16 4(V) Y
Group 2
HopX1 9.2 23.22 20 3(I) Y
HopF2 9.6 17.50 22 3(I) Y
Group 3
HopM1 3.6 4.67 4 4(P) Y
AvrE1 10.0 1.67 10 3(L) Y
Proteins in bold are encoded by genes identified in our screen. Genes from
each strain are divided into three groups: group 1, expressed as single genes;
group 2, expressed in an operon downstream from putative chaperone-
encoding genes, except HopB1 and HopX1(Pph6), which were expressed
downstream from hrpK; group 3, inconsistent translocation results.
*Criteria as defined in refs. 8, 9, 14, and 15. Criteria that did not correlate to
those of a type III effector protein are underlined.
†Bit score for the hrp-box; scores 2.0 are considered reliable; 2.0 are
underlined. Scores 0 are not listed.
‡Fold Induction  mean FACS-derived GFP fluorescence of the positive peak
divided by the mean fluorescence of uninduced cells. Negative control, empty
vector; 1-fold induction. Positive control, AvrRpm1 upstream of GFP; 122-fold
induction. NT, not tested.
§Elicited strong HR in 23 experiments as both gene and operon fusions, and
therefore included in groups 2 and 3.
¶Could not construct full-length fusions to 79AvrRpt2.
Caused tissue collapse in only one of three experiments.
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Horizontal transmission is likely a mechanism by which P.
syringae pathovars acquire type III effector genes. All but three of
the 13 sets of orthologs common to Pto and Pph6 are found
scattered throughout the genomes and plasmids, with almost no
flanking colinearity. Consequently, few extant type III effector
genes were likely present before the divergence of these two strains.
In contrast, two helper genes not linked to the hrphrc cluster,
hopAJ1 and hopAK1, are flanked by orthologous ORFs, suggesting
that they may have been present before the divergence of the two
pathovars (data not shown). These data support a mix-and-match
strategy used by P. syringae to acquire type III effector genes. The
observation that several type III effector genes are associated with
remnants of mobile elements (Fig. 2B, red asterisks) supports the
notion that horizontal transmission is a key mechanism for acqui-
sition of type III effector genes (35, 36).
Alternatively, or in addition, intra- and intergenic changes can
also contribute to the evolution of type III effector suites of P.
syringae strains. The plasmid of Pph6 (Fig. 2B) carries five type III
effector genes and ORF4 in common with, and colinear to, or-
thologs on pAV511 of Pph race 7 (Pph7) (31). However, the
avrPphF (hopF3Pph6 and hopF1Pph7) operons are found in different
locations between the two strains: on the chromosome of Pph6 (Fig.
2B) and between avrD1 and avrPphC (avrB2) on the plasmid in Pph
7 (31). The respective ORF1 and ORF2 proteins encoded from the
avrPphF operon in Pph6 are quite different from their counterparts
in Pph 7 (27% and 39% identity, respectively), hence the subclas-
sification of avrPphFPph6 as hopF3 (16). Interestingly, another copy
of ORF4 is located on the chromosome, just 3 to hopF3Pph6. This
finding suggests that a pathogenicity island located on a plasmid was
common to an ancestral pathovar of Pph6 and -7, and that subse-
quent rearrangements have occurred since their divergence. Pph6
also carries two identical HrpL-regulated genes of 433 bp (hopW1–
2Pph6 and -3Pph6) that are homologous to hopW1–1 (BLASTN  1.0 
10	83, Table 3 and ref. 16). The two fragments are oriented in the
same direction and flank a total of five type III effector genes and
a HrpL-regulated shikimate kinase-encoding gene (Fig. 2B, red
asterisks). This structure may indicate a recombination mechanism
by which the plasmid could integrateexcise from the genome, like
the PAI plasmid pFKN from P. syringae pv. maculicola M6 (37).
The recognition of any single type III effector protein by a plant
R protein will render that individual bacterium avirulent on an
otherwise normally susceptible host plant. One method to avoid
‘‘recognition’’ is inactivating the relevant type III effector genes.
The genomes of these two P. syringae are graveyards of inactive type
III effector genes. Both pathovars carry HrpL-expressed pseudo-
genes interrupted by transposable elements. When fused to
79AvrRpt2, none of these fusion proteins elicited an RPS2-
dependent HR (Table 3). Pph6 carries a nearly identical copy of
AvrB3 elsewhere in the genome, but it too has a transposon
insertion. We did not identify this gene in our screen and conse-
Fig. 2. Genome context of type III effector genes in Pto and Pph6. (A) Orthologous type III effector proteins were compared by using BLASTX analysis of deduced Pph6
proteins against the translated sequences from Pto. Significant homologies are given as % identity (%ID), % of the proteins that aligned (% Aln) and regions of
alignment; n, amino terminal, FL, full-length entire protein; C, carboxy terminal. (B) Type III effector genes are depicted along horizontal bars representing the bacterial
chromosome or plasmid (black, Pto; blue, Pph6). Marks above and below the bar are the genes encoded on the top and bottom strand, respectively. Black and purple
marks represent genes encoding type III effector genes and operons, respectively. Letter abbreviations correspond to the unified naming nomenclature of type III
effector genes. Orthologous type III effector genes are highlighted in red. Predicted mobile elements are denoted with a red asterisks. (C) The orthologous copies of
HopI1 as well as hopAB2Pto and hopAB3 occupy similar regions in their respective genomes. Flanking ORFs had 80% identity along the length of the sequence.
Orthologous genes are connected by dotted red lines. Gray boxes, orthologous flanking ORFs; black bars or boxes, Pto; blue bars or boxes, Pph6; red asterisks, mobile
elements.









quently did not test it for HrpL-regulation or its protein for
translocation. HopAB3 encodes a functional gene, but not a func-
tional type III effector protein, likely because of the loss of the
secretion signal (Table 3 and Fig. 4, which are published as
supporting information on the PNAS web site). Finally, Pph6 carries
an inactivated ortholog of hopAA1. Although it has an identifiable
hrp-box, it is not expressed in a HrpL-dependent manner, has a
premature stop codon, and is not delivered into plants. Strains may
also carry type III effectors that mask the perception of other type
III effector proteins (38–40).
We confirmed fewer type III effectors from Pto than previously
predicted both experimentally and by informatic-based analyses
(www.pseudomonas-syringae.org and refs. 7 and 15). This variance
is likely due to different assays and criteria for defining type III
effectors. Our definition is stringent, based on HrpL-dependent
expression from native promoters and the ability to translocate
full-length fusion to 79AvrRpt2 directly into plant cells. Previous
analyses used, for example, secretion of candidate type III effectors
into media after expression from the strong, constitutive npt II
promoter (8). These approaches may resurrect transcriptionally
silent or HrpL-independent ORFs as Hops (14) or lead to misclas-
sification of helper proteins as type III effector proteins.
In some cases, protein fusions expressed from the promoter of an
endogenous type III effector gene may be insufficient to produce
enough protein for delivery of an RPS2-dependent HR. This may
be the case for avrPphEPto and avrEPph6, which had some of the
lowest fold-induction ratios and maximum mean GFP fluorescence
values (1.6725 and 1.6750, respectively) of the HrpL-induced
genes in our experiments (ranges of fold-induction and maximum
GFP-fluorescence were 1.14–46.67 and 25–2,160, respectively).
However, very little protein needs to be expressed and delivered to
elicit the RPS2-dependent HR (14). These weakly HrpL-induced
genes will nevertheless be identified in our screen because of their
HrpL-dependent gene expression. These genes may require more
sensitive assays than fusions to 79AvrRpt2, which rely on their
endogenous promoters, for proper classification as type III effector
proteins.
Nearly all 79AvrRpt2 protein fusions gave reproducible positive
or negative RPS2-dependent HR results. However, a few results
were inconclusive. Some fusions to 79AvrRpt2 might be unstable,
unable to pass through the TTSS, or misfolded to preclude trig-
gering of RPS2-dependent HR. Arguing against this is our finding
that HopR1Pph6 (200 kDa before the addition of 79AvrRpt2) did
elicit RPS2-dependent HR. Therefore, we believe that few, if any,
of the higher expressed proteins were incorrectly categorized.
In summary, we created a high-throughput, near-saturating
screen for type III effector genes of P. syringae and corroborated our
biological results with bioinformatics analyses. The expeditious
nature of our screen enabled thorough screening for type III
effector genes, and our isolation of all five hrp promoters from each
strain suggests that the screen is probably saturating. Our results
with P. syringae pv. tomato and phaseolicola indicate that this
method will be useful for identifying entire suites of type III effector
genes from diverse pathovars of P. syringae whose genomes have not
been sequenced. We have targeted 13 additional strains for analyses
based on their phylogenetic relationships (32), maximizing both
evolutionary distance among strains and their respective hosts. We
envision that comparisons between pathovars will be useful in
understanding the function and evolution of type III effectors
throughout this species. These findings should be generalized to all
pathogens that rely on type III systems to colonize a wide variety
of host species.
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